Published in Graefes Arch Clin Exp Ophthalmol on July 01, 1995
Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology (2008) 2.33
Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure. Invest Ophthalmol Vis Sci (2010) 0.90
Echographic measurements of the retrobulbar optic nerve in normal and glaucomatous eyes. Br J Ophthalmol (1998) 0.82
Lipofuscin in human glaucomatous optic nerves. Exp Eye Res (2013) 0.79
Correlation between optic disc area and retinal nerve fiber layer thickness: a study on scanning laser polarimetry with variable corneal compensation. Graefes Arch Clin Exp Ophthalmol (2006) 0.77
Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma. Exp Eye Res (2016) 0.77
[Structural diagnostics of course observation for glaucoma]. Ophthalmologe (2013) 0.75
[Structural alterations during the course of glaucoma disease]. Ophthalmologe (2015) 0.75
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (2000) 6.70
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 5.60
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med (1998) 5.54
Top-down facilitation of visual recognition. Proc Natl Acad Sci U S A (2006) 5.38
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol (1993) 3.73
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem (1999) 3.72
Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes. Invest Ophthalmol Vis Sci (1988) 3.55
Human optic nerve fiber count and optic disc size. Invest Ophthalmol Vis Sci (1992) 2.94
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab (2001) 2.91
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun (2002) 2.88
Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem (1997) 2.66
Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem (1997) 2.53
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest (2001) 2.45
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med (2000) 2.44
Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol (1992) 2.36
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol (2001) 2.33
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest (1996) 2.03
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol (2000) 1.92
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol (2001) 1.89
Histomorphometry of the human optic nerve. Invest Ophthalmol Vis Sci (1990) 1.89
Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci (1989) 1.88
Direct cyclopexy for traumatic cyclodialysis with persisting hypotony. Report in 29 consecutive patients. Ophthalmology (1995) 1.88
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest (2000) 1.82
Morphometry of the human lamina cribrosa surface. Invest Ophthalmol Vis Sci (1991) 1.81
Optic disc morphometry in chronic primary open-angle glaucoma. I. Morphometric intrapapillary characteristics. Graefes Arch Clin Exp Ophthalmol (1988) 1.81
The retinal nerve fiber layer in normal eyes. Ophthalmology (1989) 1.74
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A (1994) 1.71
Optic disk morphometry in high myopia. Graefes Arch Clin Exp Ophthalmol (1988) 1.71
Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J Lab Clin Med (1994) 1.69
Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty. Ophthalmology (1999) 1.66
International ophthalmology strategic plan to preserve and restore vision-vision for the future. Am J Ophthalmol (2001) 1.65
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2001) 1.64
Glaucomatous optic nerve atrophy in small discs with low cup-to-disc ratios. Ophthalmology (1990) 1.63
Retinal nerve fiber layer thickness in human eyes. Graefes Arch Clin Exp Ophthalmol (1999) 1.59
Corneal endothelial involvement in pseudoexfoliation syndrome. Arch Ophthalmol (1993) 1.58
Quantification of aqueous melanin granules in primary pigment dispersion syndrome. Am J Ophthalmol (1998) 1.55
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest (1998) 1.51
Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet (2001) 1.50
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci (2002) 1.50
Congenital nonpigmented epithelial iris cyst after amniocentesis. Clinicopathologic report on two children. Ophthalmology (1993) 1.47
Unilateral arcus lipoides corneae with traumatic cyclodialysis in two patients. Case report. Arch Ophthalmol (1989) 1.46
Quantification of aqueous flare after phacoemulsification with intraocular lens implantation in eyes with pseudoexfoliation syndrome. Arch Ophthalmol (1999) 1.45
Surgical management of melanocytoma of the ciliary body with extrascleral extension. Am J Ophthalmol (1994) 1.44
Silicone oil-associated optic nerve degeneration. Am J Ophthalmol (2001) 1.44
Parapapillary atrophy and retinal vessel diameter in nonglaucomatous optic nerve damage. Invest Ophthalmol Vis Sci (1991) 1.43
Bilateral zonular cataract associated with the mitochondrial cytopathy of Pearson syndrome. Am J Ophthalmol (1998) 1.42
Glaucomatous parapapillary atrophy. Occurrence and correlations. Arch Ophthalmol (1992) 1.41
beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol (2000) 1.40
"Consent" vs "choice" in surgical decision-making. Ophthalmic Surg (1992) 1.39
Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res (2001) 1.39
Size of the optic nerve scleral canal and comparison with intravital determination of optic disc dimensions. Graefes Arch Clin Exp Ophthalmol (1988) 1.35
Count and density of human retinal photoreceptors. Graefes Arch Clin Exp Ophthalmol (1992) 1.35
Anterior chamber depth and complications during cataract surgery in eyes with pseudoexfoliation syndrome. Am J Ophthalmol (2000) 1.34
Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue. Arch Ophthalmol (1991) 1.32
Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest Ophthalmol Vis Sci (1995) 1.31
Optic disc histomorphometry in normal eyes and eyes with secondary angle-closure glaucoma. II. Parapapillary region. Graefes Arch Clin Exp Ophthalmol (1992) 1.28
Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J Biol Chem (1998) 1.27
Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A (1994) 1.25
[Block excision with tectonic corneoscleroplasty for cystic and/or diffuse epithelial invasion of the anterior eye segment. Report of 51 consecutive patients (1980-1996)]. Klin Monbl Augenheilkd (1997) 1.24
AB-polymer networks based on oligo(epsilon-caprolactone) segments showing shape-memory properties. Proc Natl Acad Sci U S A (2001) 1.24
Decreased choroidal thickness in eyes with secondary angle closure glaucoma. An aetiological factor for deep retinal changes in glaucoma? Br J Ophthalmol (1993) 1.23
Parapapillary chorioretinal atrophy in normal and glaucoma eyes. II. Correlations. Invest Ophthalmol Vis Sci (1989) 1.21
Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood (1993) 1.20
Ochrobactrum anthropi endophthalmitis after uncomplicated cataract surgery. Am J Ophthalmol (1996) 1.19
Epithelial transformation of the corneal endothelium in forceps birth-injury-associated keratopathy. Cornea (1993) 1.19
Parapapillary retinal vessel diameter in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci (1989) 1.19
[Foveolar aplasia in tyrosinase-positive oculocutaneous albinisim (author's transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1976) 1.18
Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia (2003) 1.17
Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats. Mol Pharmacol (1997) 1.16
Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage. J Exp Med (1999) 1.15
Parapapillary retinal vessel diameter in normal and glaucoma eyes. II. Correlations. Invest Ophthalmol Vis Sci (1989) 1.14
[Secondary glaucomas caused by intraocular epithelial invasion. A clinico-pathologic study of 30 patients]. Klin Monbl Augenheilkd (1988) 1.14
Optic disc morphometry in chronic primary open-angle glaucoma. II. Correlation of the intrapapillary morphometric data to visual field indices. Graefes Arch Clin Exp Ophthalmol (1988) 1.13
Emergency response training: strategies for enhancing real-world performance. J Hazard Mater (2000) 1.12
Anterior ischemic optic neuropathy: nonarteritic form in small and giant cell arteritis in normal sized optic discs. Int Ophthalmol (1988) 1.11
Changing indications for penetrating keratoplasty: histopathology of 1,250 corneal buttons. Cornea (1998) 1.11
A histopathologic study of zonular instability in pseudoexfoliation syndrome. Am J Ophthalmol (1994) 1.11
Direct clinico-histological correlation of parapapillary chorioretinal atrophy. Br J Ophthalmol (1993) 1.09
Correlations of the neuroretinal rim area with ocular and general parameters in normal eyes. Ophthalmic Res (1988) 1.08
Colonoscopy in mice. Surg Endosc (2001) 1.08
Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant (2007) 1.07
Variability of the real dimensions of normal human optic discs. Graefes Arch Clin Exp Ophthalmol (1988) 1.06
[Intraocular silicone oil tamponade. A clinico-pathologic study of 36 enucleated eyes]. Ophthalmologe (1996) 1.06
A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology (1995) 1.06
Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization. Cornea (1998) 1.06
Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas. Am J Ophthalmol (1998) 1.05
Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci (1997) 1.04
Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study. Ophthalmology (1994) 1.03
Pseudoglaucomatous physiologic large cups. Am J Ophthalmol (1989) 1.03
Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontol 2000 (2000) 1.03